HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

Clinical trials for HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Quarterly shot could replace daily breast cancer pills

Disease control Not yet recruiting

This study is testing a new quarterly injection of the hormone therapy drug letrozole to see if it gets into the bloodstream as well as the standard daily pill. It will involve 120 post-menopausal women who have already been treated for early-stage, hormone-positive breast cancer…

Matched conditions: HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

Get alerted when new HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER trials appear

Quarterly shot could replace daily breast cancer pills